Impact of negative air pressure in ICU rooms on the risk of pulmonary aspergillosis in COVID-19 patients.
Identifieur interne : 000D31 ( Main/Exploration ); précédent : 000D30; suivant : 000D32Impact of negative air pressure in ICU rooms on the risk of pulmonary aspergillosis in COVID-19 patients.
Auteurs : Philippe Ichai [France] ; Faouzi Saliba [France] ; Patricia Baune [France] ; Asma Daoud [France] ; Audrey Coilly [France] ; Didier Samuel [France]Source :
- Critical care (London, England) [ 1466-609X ] ; 2020.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen (MeSH), Antifongiques (usage thérapeutique), Aspergillose pulmonaire (traitement médicamenteux), Aspergillose pulmonaire (transmission), Betacoronavirus (MeSH), Conception et construction d'hôpitaux (MeSH), Facteurs de risque (MeSH), Femelle (MeSH), Humains (MeSH), Infections à coronavirus (complications), Microbiologie de l'air (MeSH), Mâle (MeSH), Pandémies (MeSH), Pneumopathie virale (complications), Pression de l'air (MeSH), Sujet âgé (MeSH), Surveillance de l'environnement (méthodes), Unités de soins intensifs (MeSH), Ventilation (MeSH), Épidémies de maladies (MeSH).
- MESH :
- méthodes : Surveillance de l'environnement.
- traitement médicamenteux : Aspergillose pulmonaire.
- usage thérapeutique : Antifongiques, Aspergillose pulmonaire, Infections à coronavirus, Pneumopathie virale.
- Adulte d'âge moyen, Betacoronavirus, Conception et construction d'hôpitaux, Facteurs de risque, Femelle, Humains, Microbiologie de l'air, Mâle, Pandémies, Pression de l'air, Sujet âgé, Unités de soins intensifs, Ventilation, Épidémies de maladies.
English descriptors
- KwdEn :
- Aged (MeSH), Air Microbiology (MeSH), Air Pressure (MeSH), Antifungal Agents (therapeutic use), Betacoronavirus (MeSH), Coronavirus Infections (complications), Disease Outbreaks (MeSH), Environmental Monitoring (methods), Female (MeSH), Hospital Design and Construction (MeSH), Humans (MeSH), Intensive Care Units (MeSH), Male (MeSH), Middle Aged (MeSH), Pandemics (MeSH), Pneumonia, Viral (complications), Pulmonary Aspergillosis (drug therapy), Pulmonary Aspergillosis (transmission), Risk Factors (MeSH), Ventilation (MeSH).
- MESH :
- chemical , therapeutic use : Antifungal Agents.
- complications : Coronavirus Infections, Pneumonia, Viral.
- drug therapy : Pulmonary Aspergillosis.
- methods : Environmental Monitoring.
- transmission : Pulmonary Aspergillosis.
- Aged, Air Microbiology, Air Pressure, Betacoronavirus, Disease Outbreaks, Female, Hospital Design and Construction, Humans, Intensive Care Units, Male, Middle Aged, Pandemics, Risk Factors, Ventilation.
DOI: 10.1186/s13054-020-03221-w
PubMed: 32867810
PubMed Central: PMC7458783
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Impact of negative air pressure in ICU rooms on the risk of pulmonary aspergillosis in COVID-19 patients.</title><author><name sortKey="Ichai, Philippe" sort="Ichai, Philippe" uniqKey="Ichai P" first="Philippe" last="Ichai">Philippe Ichai</name><affiliation wicri:level="3"><nlm:affiliation>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif, France. philippe.ichai@aphp.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Villejuif</settlement></placeName></affiliation></author><author><name sortKey="Saliba, Faouzi" sort="Saliba, Faouzi" uniqKey="Saliba F" first="Faouzi" last="Saliba">Faouzi Saliba</name><affiliation wicri:level="3"><nlm:affiliation>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Villejuif</settlement></placeName></affiliation></author><author><name sortKey="Baune, Patricia" sort="Baune, Patricia" uniqKey="Baune P" first="Patricia" last="Baune">Patricia Baune</name><affiliation wicri:level="3"><nlm:affiliation>Infection Control Team, AP-HP Hôpital Paul-Brousse, F-94800, Villejuif, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Infection Control Team, AP-HP Hôpital Paul-Brousse, F-94800, Villejuif</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Villejuif</settlement></placeName></affiliation></author><author><name sortKey="Daoud, Asma" sort="Daoud, Asma" uniqKey="Daoud A" first="Asma" last="Daoud">Asma Daoud</name><affiliation wicri:level="3"><nlm:affiliation>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Villejuif</settlement></placeName></affiliation></author><author><name sortKey="Coilly, Audrey" sort="Coilly, Audrey" uniqKey="Coilly A" first="Audrey" last="Coilly">Audrey Coilly</name><affiliation wicri:level="3"><nlm:affiliation>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Villejuif</settlement></placeName></affiliation></author><author><name sortKey="Samuel, Didier" sort="Samuel, Didier" uniqKey="Samuel D" first="Didier" last="Samuel">Didier Samuel</name><affiliation wicri:level="3"><nlm:affiliation>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Villejuif</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32867810</idno><idno type="pmid">32867810</idno><idno type="doi">10.1186/s13054-020-03221-w</idno><idno type="pmc">PMC7458783</idno><idno type="wicri:Area/Main/Corpus">000278</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000278</idno><idno type="wicri:Area/Main/Curation">000278</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000278</idno><idno type="wicri:Area/Main/Exploration">000278</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Impact of negative air pressure in ICU rooms on the risk of pulmonary aspergillosis in COVID-19 patients.</title><author><name sortKey="Ichai, Philippe" sort="Ichai, Philippe" uniqKey="Ichai P" first="Philippe" last="Ichai">Philippe Ichai</name><affiliation wicri:level="3"><nlm:affiliation>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif, France. philippe.ichai@aphp.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Villejuif</settlement></placeName></affiliation></author><author><name sortKey="Saliba, Faouzi" sort="Saliba, Faouzi" uniqKey="Saliba F" first="Faouzi" last="Saliba">Faouzi Saliba</name><affiliation wicri:level="3"><nlm:affiliation>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Villejuif</settlement></placeName></affiliation></author><author><name sortKey="Baune, Patricia" sort="Baune, Patricia" uniqKey="Baune P" first="Patricia" last="Baune">Patricia Baune</name><affiliation wicri:level="3"><nlm:affiliation>Infection Control Team, AP-HP Hôpital Paul-Brousse, F-94800, Villejuif, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Infection Control Team, AP-HP Hôpital Paul-Brousse, F-94800, Villejuif</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Villejuif</settlement></placeName></affiliation></author><author><name sortKey="Daoud, Asma" sort="Daoud, Asma" uniqKey="Daoud A" first="Asma" last="Daoud">Asma Daoud</name><affiliation wicri:level="3"><nlm:affiliation>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Villejuif</settlement></placeName></affiliation></author><author><name sortKey="Coilly, Audrey" sort="Coilly, Audrey" uniqKey="Coilly A" first="Audrey" last="Coilly">Audrey Coilly</name><affiliation wicri:level="3"><nlm:affiliation>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Villejuif</settlement></placeName></affiliation></author><author><name sortKey="Samuel, Didier" sort="Samuel, Didier" uniqKey="Samuel D" first="Didier" last="Samuel">Didier Samuel</name><affiliation wicri:level="3"><nlm:affiliation>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Villejuif</settlement></placeName></affiliation></author></analytic><series><title level="j">Critical care (London, England)</title><idno type="eISSN">1466-609X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term><term>Air Microbiology (MeSH)</term><term>Air Pressure (MeSH)</term><term>Antifungal Agents (therapeutic use)</term><term>Betacoronavirus (MeSH)</term><term>Coronavirus Infections (complications)</term><term>Disease Outbreaks (MeSH)</term><term>Environmental Monitoring (methods)</term><term>Female (MeSH)</term><term>Hospital Design and Construction (MeSH)</term><term>Humans (MeSH)</term><term>Intensive Care Units (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (complications)</term><term>Pulmonary Aspergillosis (drug therapy)</term><term>Pulmonary Aspergillosis (transmission)</term><term>Risk Factors (MeSH)</term><term>Ventilation (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen (MeSH)</term><term>Antifongiques (usage thérapeutique)</term><term>Aspergillose pulmonaire (traitement médicamenteux)</term><term>Aspergillose pulmonaire (transmission)</term><term>Betacoronavirus (MeSH)</term><term>Conception et construction d'hôpitaux (MeSH)</term><term>Facteurs de risque (MeSH)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (complications)</term><term>Microbiologie de l'air (MeSH)</term><term>Mâle (MeSH)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (complications)</term><term>Pression de l'air (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Surveillance de l'environnement (méthodes)</term><term>Unités de soins intensifs (MeSH)</term><term>Ventilation (MeSH)</term><term>Épidémies de maladies (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antifungal Agents</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Pulmonary Aspergillosis</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Environmental Monitoring</term></keywords><keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Surveillance de l'environnement</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Aspergillose pulmonaire</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Pulmonary Aspergillosis</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antifongiques</term><term>Aspergillose pulmonaire</term><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Air Microbiology</term><term>Air Pressure</term><term>Betacoronavirus</term><term>Disease Outbreaks</term><term>Female</term><term>Hospital Design and Construction</term><term>Humans</term><term>Intensive Care Units</term><term>Male</term><term>Middle Aged</term><term>Pandemics</term><term>Risk Factors</term><term>Ventilation</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Betacoronavirus</term><term>Conception et construction d'hôpitaux</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Microbiologie de l'air</term><term>Mâle</term><term>Pandémies</term><term>Pression de l'air</term><term>Sujet âgé</term><term>Unités de soins intensifs</term><term>Ventilation</term><term>Épidémies de maladies</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32867810</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>03</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>09</Month><Day>01</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Impact of negative air pressure in ICU rooms on the risk of pulmonary aspergillosis in COVID-19 patients.</ArticleTitle><Pagination><MedlinePgn>538</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-020-03221-w</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ichai</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6182-4802</Identifier><AffiliationInfo><Affiliation>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif, France. philippe.ichai@aphp.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saliba</LastName><ForeName>Faouzi</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baune</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Infection Control Team, AP-HP Hôpital Paul-Brousse, F-94800, Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daoud</LastName><ForeName>Asma</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coilly</LastName><ForeName>Audrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samuel</LastName><ForeName>Didier</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Liver Intensive Care Unit, Centre Hépato-Biliaire, AP-HP, Hôpital Paul-Brousse, Université Paris-Saclay, Inserm U1193, 12 Avenue Paul Vaillant Couturier, F-94804, Villejuif, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000935">Antifungal Agents</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000391" MajorTopicYN="N">Air Microbiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000399" MajorTopicYN="N">Air Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000935" MajorTopicYN="N">Antifungal Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004784" MajorTopicYN="N">Environmental Monitoring</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006749" MajorTopicYN="Y">Hospital Design and Construction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055732" MajorTopicYN="N">Pulmonary Aspergillosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014691" MajorTopicYN="Y">Ventilation</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>07</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>08</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32867810</ArticleId><ArticleId IdType="doi">10.1186/s13054-020-03221-w</ArticleId><ArticleId IdType="pii">10.1186/s13054-020-03221-w</ArticleId><ArticleId IdType="pmc">PMC7458783</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet Respir Med. 2020 Jun;8(6):e48-e49</Citation><ArticleIdList><ArticleId IdType="pubmed">32445626</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hosp Infect. 2004 Feb;56(2):93-100; quiz 163</Citation><ArticleIdList><ArticleId IdType="pubmed">15019219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mycoses. 2020 Jun;63(6):528-534</Citation><ArticleIdList><ArticleId IdType="pubmed">32339350</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2020 Mar 11;24(1):84</Citation><ArticleIdList><ArticleId IdType="pubmed">32160910</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Infect Control. 2018 May;46(5):590-593</Citation><ArticleIdList><ArticleId IdType="pubmed">29307752</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Respir Med. 2020 May;8(5):506-517</Citation><ArticleIdList><ArticleId IdType="pubmed">32272080</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Île-de-France</li></region><settlement><li>Villejuif</li></settlement></list><tree><country name="France"><region name="Île-de-France"><name sortKey="Ichai, Philippe" sort="Ichai, Philippe" uniqKey="Ichai P" first="Philippe" last="Ichai">Philippe Ichai</name></region><name sortKey="Baune, Patricia" sort="Baune, Patricia" uniqKey="Baune P" first="Patricia" last="Baune">Patricia Baune</name><name sortKey="Coilly, Audrey" sort="Coilly, Audrey" uniqKey="Coilly A" first="Audrey" last="Coilly">Audrey Coilly</name><name sortKey="Daoud, Asma" sort="Daoud, Asma" uniqKey="Daoud A" first="Asma" last="Daoud">Asma Daoud</name><name sortKey="Saliba, Faouzi" sort="Saliba, Faouzi" uniqKey="Saliba F" first="Faouzi" last="Saliba">Faouzi Saliba</name><name sortKey="Samuel, Didier" sort="Samuel, Didier" uniqKey="Samuel D" first="Didier" last="Samuel">Didier Samuel</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D31 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D31 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32867810
|texte= Impact of negative air pressure in ICU rooms on the risk of pulmonary aspergillosis in COVID-19 patients.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32867810" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |